Not displaying correctly?
Read in web browser
December 2020

Dear Research Community,

Just a quick note to highlight our ongoing Science Communications Series. This month’s session focuses on how to make a graphical abstract. Join us Tuesday December 8th at 1:30pm.

We had an immense number of stories written about Jefferson research over the last month – such as the novel approach for treating MS, research on the impact of expanding our Jefferson student-food pantry from East Falls to Center City, and ways Jefferson is battling health disparities by engaging marginalized communities in the research enterprise. Delve into some of Jefferson’s work below.

As always, please reach out to us with updates on research publications from your department, and your teams. We rely on you to help us shine a light on Jefferson research: Research.News@Jefferson.edu.

Happy Holidays,
Edyta + Karuna
Science Writers, Marketing and Communications

 
Highlight from Twitter
 

Andrew South shared his research on a virtual stage this month with celebrities like Eddie Vedder, Billie Eilish, Laura Dern, and others, to benefit patients with Butterfly Disease.

 
Click to see full tweet
 
Venture into Cures EB event flier
 
 
How Can Researchers Engage with Marginalized Communities to Better Understand Health Disparities?
by Karuna Meda
 

Creating practices for researchers to include the voices of the communities they work with.  

 
Read the story
 
Jenny Martinez
 
A Novel Immunotherapy Proves Effective in Animal Models of Multiple Sclerosis
by Karuna Meda
 

Jefferson researchers develop an approach to specifically impede the autoimmune response that drives the disease, while leaving the rest of the immune system fully functioning.

 
Read the story
 
A white mouse sitting in a petri dish
 
When the COVID-19 Pandemic Hit, JIB Stepped Into the Spotlight
by Brian Hickey
 

The Jefferson Institute for Bioprocessing is uniquely qualified to train students and industry professionals at the time it is needed most.

 
Read the story
 
Jefferson Institute for Bioprocessing
 
JeffSolves MedTech Inspires Next Generation of Innovators
by Mike Bederka
 

Industrial design and medical students work together to develop healthcare solutions.

 
Read more »
 
Medical devices and parts
 
Browse All Recently Highlighted Research
 

What I Wish People Knew about Surviving Breast Cancer
Garber, Vaughan- Briggs, Schimanski | Cancer | 11.3

How to Get Intimacy Back after Cancer Treatment

Simone + Taylor | Cancer | 11.3

A Novel Immunotherapy Proves Effective in Animal Models of Multiple Sclerosis
Rostami | Neuro | 11.4

 

JeffSolves MedTech Inspires Next Generation of Innovators
Multiple sources | Jeff Solves | 11.9

Original tweet - Gastrointestinal bleeding after LVAD surgery

Tchantchaleishvili | 11.10

Original tweet - Potential change in practice of gallbladder surgery for acute cholecystitis: JACS

Palazzo, Rios-Diaz, Woodward | 11.10

Jefferson Health Named Finalist in CMS Artificial Intelligence Health Outcomes Challenge

Multiple sources | Comp Med | 11.12

Original tweet - EB Research Partnership Event
South | Dermatology | 11/16

Ramily Market Expansion Works to Ease Food Insecurity Burden

Rowland | Population Health | 11.20

When the COVID-19 Pandemic Hit, JIB Stepped Into the Spotlight
Shamlou + Toner | JIB | 11.23

Dr. Isidore Rigoutsos Elected AAAS Fellow for 2020
Rigoutsos | Comp Med | 11.24

How Can Researchers Engage with Marginalized Communities to Better Understand Health Disparities?

Martinez | OT | 11.30

Close to the Bone: SKCC Investigators Uncover Link between Mitochondrial Metabolism and Chondrosarcoma

Outschoorn | Cancer | 11.30

 
Independently Reported Stories from the Media:
 

DURATION-8: Exenatide and Dapagliflozin Effects Present 2 Years After Randomization - Endocrinology Network
Among short-lived diabetes treatments, a combo therapy lasts - McKnight's Long Term Care News
Combo Drug Treatment for Type 2 Diabetes Remains Effective After 2 Years- Pharmacy Times
Drug Combo Offers Long-Term Glycemic Control in T2DM - HealthDay - Physician's Briefing

Serge Jabbour | Endocrinology

 

New Drug Offers Hope Against MS – HealthDay – syndicated to US News & World Report & others
Treating multiple sclerosis with an antigen-specific cell therapy - Fierce Biotech
Extracellular Vesicles Harnessed as Immunotherapy against Multiple Sclerosis in Mouse Models – GEN
Team identifies new potential approach to treat multiple sclerosis -- Drug Target Review
Small, Myelin-rich Vesicles May Help Control Immune Response in MS, Animal Study Shows -- Multiple Sclerosis News Today
New Immunotherapy Shows Promise for MS – LabRoots
Researchers discover new tool in fight against multiple sclerosis -- KYW NewsRadio
MS vaccine using your own brain cells -- Naked Scientist podcast
A.M. Rostami | Neuro

 

Sign up for this newsletter here.

 

Have news to share? Get in touch.